Sydnexis

Drug Discovery · Del Mar, CA · Founded 2014 · Privately Held (backing)

Developer of a eyecare medicine and drug designed to treat myopia. Sydnexis is based in Del Mar, CA and was founded in 2014. Its last reported valuation was $90 million in Aug 2021. It has raised $76.5 million across 4 recorded rounds; the latest was a $20 million early-stage round in Apr 2025.

Last reported valuation
$90.0M
Oct 2026
Priced at
—
Total raised
$76.5M
Last round
Early Stage VC
Apr 2025

Who backs Sydnexis?

6 investors
InvestorType
RA Capital ManagementAsset manager
Longitude CapitalVenture capital
Bluestem Capital Company—
Medicxi—
SC Master Fund—
Visionary Venture Fund—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Sydnexis investors

6 investors are on record for Sydnexis, including RA Capital Management, Longitude Capital, Bluestem Capital Company and Medicxi. The early-stage round in Apr 2025 drew 23 investors.

Free account
More of Sydnexis with a free account
  • ·Watch Sydnexis: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Sydnexis in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View